By Admin
Health Impact News
From Syracuse.com:
The maker of a generic version of a popular heartburn medication is stopping worldwide distribution over concerns the drug could be contaminated with a cancer-causing substance.
Novartis AG’s Sandoz unit said Wednesday it would stop distribution of generic versions of the stomach drug Zantac after regulators in the U.S. and Europe began investigating the potential contamination, according to Bloomberg. Some versions of Zantac, also known by the generic name ranitidine, have been recalled in Europe and Canada.
Regulators first said last week they were looking into the potential contamination. Concerns arose …read more
Source: Health Impact News
- Rating:
- Views:83 views
- Categories: Health
Thanks! Share it with your friends!
Tweet
Share
Pin It
LinkedIn
Google+
Reddit
Tumblr